
Explore Impella® Technology - Abiomed
Learn more about how the FDA-approved Impella, the world's smallest heart pump, is safe, effective and supports your heart during a procedure. Hear the stories of patients and explore the latest innovations in Impella technology.
Impella heart pump: Cost, risks, insertion procedure, and more
2022年8月15日 · The Impella heart pump is a small pump that a healthcare professional can insert without surgery. It can help maintain blood flow in people who have CAD, are recovering from cardiogenic shock,...
The Impella Device: Historical Background, Clinical …
The Impella device is a catheter-based miniaturized ventricular assist device that pumps blood from left ventricle (LV) into ascending aorta and responsible for systemic circulation at an upper rate between 2.5 and 5.0 L/min.
Frequently Asked Questions | Impella.com
Impella is an FDA-approved heart pump used to support the heart during a percutaneous revascularization procedure. An Impella heart pump-supported procedure is performed by an Interventional Cardiologist and could greatly improve heart failure and coronary artery disease (CAD) patients’ outcomes—including patients who were turned down for ...
Explore the Minimally Invasive Impella CP® with SmartAssist® Heart …
The Impella CP with SmartAssist heart pump is designated as safe and effective by the FDA for use during high-risk PCI procedures and for patients in cardiogenic shock. It is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery.
Explore the Minimally Invasive Impella 5.5® with SmartAssist® Heart …
Learn about how the FDA-approved Impella 5.5 with SmartAssist supports your heart with real-time intelligence. See if Impella® is right for you.
A Review of the Impella Devices - PMC - PubMed Central (PMC)
The Impella device (Abiomed) is an intravascular microaxial blood pump that provides temporary MCS to patients, thereby reducing the workload of the heart and improving systemic circulation.
Protected PCI with Impella | Heart Recovery is Possible
Impella is the only U.S. FDA-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI
Johnson & Johnson MedTech to Highlight Latest Advancements in Heart …
Danvers, Mass. – March 27, 2025 – Johnson & Johnson MedTech, the global leader in heart recovery, will feature the latest evidence demonstrating the survival benefit of Impella ® heart pump technology at the American College of Cardiology’s 74th Annual Scientific Sessions & Expo (ACC.25), taking place in Chicago from March 29-31, 2025. Last month, the ACC and the …
Outcomes of Surgically Implanted Impella Microaxial Flow Pump in Heart …
6 天之前 · On one hand, Impella 5.5 can be used as a bridge-to-recovery, facilitated by medical therapy, arrhythmia management, and surgical or percutaneous interventions 30-32. On the other hand, Impella 5.5 can be used as a bridge to heart replacement therapy.